Is Sangani Hospital overvalued or undervalued?

As of 5 September 2025, the valuation grade for Sangani Hospital has moved from attractive to fair. The company is currently fairly valued based on its financial ratios, with a PE ratio of 38.03, an EV to EBITDA of 32.28, and a ROE of 7.73%. In comparison to its peers, Apollo Hospitals, which is rated attractive, has a significantly higher PE ratio of 71.31, while Narayana Hrudaya, rated expensive, shows a PE of 46.06.
Despite the recent downgrade in valuation grade, Sangani Hospital has demonstrated strong stock performance, particularly over the past year with a return of 63.62%, contrasting with a -1.61% return for the Sensex. This suggests that while the stock may be fairly valued now, its recent performance indicates a potential for growth relative to the broader market.